T

Tabula

Develops ML-guided, programmable antimicrobials

Research Scientist

Full-Time
No salary listed
Expert
PhD
Madison, WI, USA+1 moreMore locations: San Francisco, CA, USA
In Person
Biology & BiotechQuantitative Biology & Biostatistics

About the job

Requirements
  • A Ph.D. in Physics or a closely related quantitative field such as applied mathematics or computational science, or equivalent research experience.
  • A strong background in numerical methods, large-scale simulation, and modeling complex dynamical systems, including systems governed by partial differential equations.
  • Depth in one or more of statistical mechanics, optimization theory, probabilistic and statistical methods, and numerical stability and error analysis.
  • Experience with large-scale scientific computing and high-performance computing environments.
  • Fluency in Python and the modern scientific-computing stack.
  • Good research judgment about which ideas are worth testing and how to evaluate them.
  • Comfort working in an early-stage environment where difficult problems and the path forward are still being defined.
  • Ability to work closely with domain experts outside one's own field.
Responsibilities
  • Develop physics-based theoretical and computational models of phage–bacteria infection dynamics using numerical simulation, statistical mechanics, and optimization theory.
  • Investigate the biophysics of phage infection, including binding kinetics, replication dynamics, and population-level interactions, and translate these phenomena into tractable mathematical and computational form.
  • Design and implement numerical methods and software for large-scale simulation and analysis of physical systems.
  • Perform mathematical analysis of the models, including numerical stability analysis, error analysis, and validation against experimental data.
  • Analyze experimental data using mathematical and statistical methods to infer physical parameters and constrain the models.
  • Design and conduct computational experiments in close coordination with wet-lab scientists to test and refine the models.
  • Help define the research roadmap for improving the models over time and build practices around experimentation, evaluation, and reproducibility.
  • Help a small team build an AI-first therapeutics company focused on developing real therapies.
Desired Qualifications
  • Familiarity with the modern machine learning stack, such as PyTorch.
  • Substantial modeling and simulation work rather than building products solely on top of model APIs.
  • Experience designing experiments and learning from ambiguous results.
  • Interest in applying physics and computation to therapeutics and real-world outcomes.
  • Interest in helping build a company where computational and physics-based research is central.

About the company

Tabula Bioscience uses machine learning to improve disease prediction and personalized medicine. Its core product aims to design programmable, strain-specific antimicrobials that target bacteria via bacteriophages, with R&D focused on phage therapy and gram-negative bacteria. The models leverage unlabeled genomic data from humans and other species, incorporate expert priors and epigenetic information, and use probabilistic programming to build mechanistic biological explanations. The goal is to narrow the gap between heritability and prediction to enable more effective, individualized treatments.

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • August 2026 site says Tabula is treating real patients six months after launch.
  • 2026 hiring shows active Madison phage R&D on E. coli, Pseudomonas, and NGS.
  • Investors include George Church, Michael Seibel, Emmett Shear, Maven Ventures, and Version One.

What critics are saying

  • PitchBook still shows only a 2022 $2M seed, signaling thin capitalization.
  • Tabula’s 2026 job ads target temporary bench labor, not scaled manufacturing.
  • One failed clinical run in 2026-2027 ends Tabula’s financing and platform credibility.

What makes Tabula unique

  • Ammon Bartram and Michael Poon combine Triplebyte, Twitch, MIT, and polygenic-screening experience.
  • Tabula’s August 2026 site claims AI designs DNA for individual human infections.
  • Forward BIOLABS lists Tabula as a precision antimicrobial therapy startup.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Paid Vacation
  • 401(k) Company Match